The 4th Annual UCI Health Hematology Symposium will feature regional and national experts bringing you state-of-the-art updates on Immune Checkpoint Inhibitors, Myeloproliferative Neoplasms, AML, Bleeding Disorders, Transfusion Medicine and others. We will also feature a Case Conference segment with individual case presentations and interactive discussion. We hope to see you at the 4th Annual UCI Health Hematology Symposium.
Date: Saturday, May 11, 2019
Location: Westin South Coast Plaza, 686 Anton Blvd, Costa Mesa, CA 92626
Providers and Healthcare Professionals - $0.00
For more information, please contact Christopher Song at csong3@uci.edu or 714-456-6589.
Begin | End | Session description | ||
7:50 a.m. | 8 a.m. | Welcome and Course introduction | ||
Eric Salazar, MD | ||||
8 a.m. | 8:50 a.m. | Laboratory Diagnosis of Bleeding Disorders | ||
Edward Nelson, MD | ||||
8:50 a.m. | 9:40 a.m. | Updates in Transfusion Medicine | ||
Minh-Ha Tran, DO | ||||
9:40 a.m. | 9:55 a.m. | Break & Vendor Exhibit | ||
9:55 a.m. | 10:45 a.m. |
Updates on the MDS-AML Spectrum |
||
Deepa Jeyakumar, MD | ||||
10:45 a.m. | 11:35 a.m. | Advances in Immunotherapy for Leukemia | ||
Rishikesh Chavan, MD | ||||
11:35 a.m. | 12:35 p.m. | Lunch & Vendor Exhibit | ||
12:35 p.m. | 1:25 p.m. | New Agents in Benign Hematology | ||
Srila Gopal, MBBS | ||||
1:25 p.m. | 2:15 p.m. |
Updates in Iron Overload |
||
Kanwarpal Kahlon, MD | ||||
2:15 p.m. | 2:30 p.m. |
Break & Vendor Exhibit |
||
2:30 p.m. | 3:20 p.m. | Chronic Lymphocytic Leukemia | ||
Susan O’Brien, MD | ||||
3:20 p.m. | 4:10 p.m. | DOAC in VTE Cancer Patients | ||
Omar Darwish, MD | ||||
4:10 p.m. | 4:20 p.m. | Closing Remarks | ||
Accreditation — The UC Irvine School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation statement — The UC Irvine School of Medicine designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.